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Abstract
Fatty acids in adipose tissue share dietary sources and metabolic pathways and therefore
occur in patterns. The aim of the present study was to investigate the association between
adipose tissue fatty acid patterns identified by the data-driven dimension-reducing method
treelet transform and the risk of atrial fibrillation. A total of 57,053 Danish men and women
aged 50–64 years participating in the Diet, Cancer and Health cohort had an adipose tissue
biopsy taken at baseline. During a median follow-up of 14.6 years, a total of 4,710 partici-
pants developed atrial fibrillation or atrial flutter. Adipose tissue biopsies were analysed for
fatty acid content by gas chromatography for all cases of atrial fibrillation and for a randomly
drawn subcohort (n = 3,500) representative for the entire cohort. Hazard ratios with 95%
confidence intervals for atrial fibrillation according to quintiles of factor scores were deter-
mined by weighted Cox proportional hazards regression analyses for men and women sep-
arately. From the 32 fatty acids measured, 7 major factors/patterns of fatty acids were
identified using treelet transform. We found that a pattern consisting of n-6 polyunsaturated
fatty acids (PUFA) (except linoleic acid) was associated with a lower hazard of atrial fibrilla-
tion. Patterns consisting of marine n-3 PUFA and containing n-9 fatty acids were associated
with a lower hazard of atrial fibrillation in women. In conclusion, patterns of fatty acids in adi-
pose tissue identified by treelet transform may be differentially associated with the risk of
atrial fibrillation.
Introduction
Atrial fibrillation (AF) is a common cardiac arrhythmia with a prevalence of 1–2% in the gen-
eral population [1], which is believed to rise substantially due to the aging population, in addi-
tion to an increase in established risk factors for AF such as diabetes mellitus [2]. AF is
associated with higher morbidity including a 5-fold higher risk of stroke and a 3-fold higher
risk of congestive heart failure [1,3–5] and constitutes a serious public health problem.
Previous studies have suggested that certain fatty acids may be associated with development
of AF. The mechanisms behind which fatty acids may effect development of AF is diverse and
PLOS ONE | https://doi.org/10.1371/journal.pone.0208833 December 11, 2018 1 / 14
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Dinesen PT, Rix TA, Joensen AM, Dahm
CC, Lundbye-Christensen S, Schmidt EB, et al.
(2018) Patterns of adipose tissue fatty acids and
the risk of atrial fibrillation: A case-cohort study.
PLoS ONE 13(12): e0208833. https://doi.org/
10.1371/journal.pone.0208833
Editor: Gregory Shearer, The Pennsylvania State
University, UNITED STATES
Received: July 5, 2018
Accepted: November 24, 2018
Published: December 11, 2018
Copyright: © 2018 Dinesen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Regarding data
availability, data are available from the Diet, Cancer
and Health Institutional Data Access (https://www.
cancer.dk/research/diet-genes-environment/
dgedch/). To access data, an application must be
submitted to and approved by the Scientific Board.
Furthermore, as data contain potentially identifying
or sensitive information, access to data has to be
registered and approved by The Danish Data
Protection Agency (https://www.datatilsynet.dk/
english/the-danish-data-protection-agency). The
depends on the fatty acids involved. For saturated fatty acids the proposed mechanism has
been apoptosis due to palmitic acid ceramide affecting permeability of the outer mitochondrial
membrane [6–8], while marine n-3 polyunsaturated fatty acids (PUFA) have been suggested
to have a rhythm-stabilising effect caused by effects on ion channels and membrane fluidity
[9].
Previous studies have explored the potential associations for individual adipose tissue fatty
acids but not the association between patterns of fatty acids in adipose tissue and development
of AF [10,11]. As individual fatty acids share dietary sources and metabolic pathways, they are
highly correlated. Fatty acid patterns in adipose tissue respect that individual fatty acids share
dietary sources and metabolic pathways making the interpretation of data more clear than
exploring individual fatty acids [12–15]. The statistical method treelet transform is a dimen-
sion-reduction method which takes correlations between variables into account and may be
used to generate patterns of fatty acids contained in adipose tissue [16,17].
The purpose of this study was to investigate the association between fatty acid patterns in
adipose tissue identified by the treelet transform and the long-term risk of AF in a Danish
cohort.
Material and methods
Study population
The Danish Diet, Cancer and Health cohort was established between 1993 and 1997 and has
previously been described in detail [18]. Briefly, 160,725 individuals born in Denmark, not reg-
istered with a diagnosis of cancer in the Danish Cancer Registry and aged 50–64 years received
an invitation for participation, which was accepted by 57,053 subjects (29,875 women and
27,178 men).
Participants answered questionnaires on diet, lifestyle, medications and health at baseline.
Blood pressure and anthropometric measurements were performed, and biological material
was collected. Participants with a delayed registration of cancer in the Danish Cancer Register
were later excluded. For this study, participants with thyroid disease and/or documented AF/
atrial flutter (AFL) prior to recruitment were also excluded (see Fig 1).
A randomly drawn subcohort of 3,500 participants representative for the entire cohort was
used in this case-cohort study.
The study participants gave written informed consent and the research was conducted
according to the Declaration of Helsinki. The Danish Data Protection Agency (project num-
ber: 2015–186) and the Ethics Committee in the North Denmark Region (project number: N-
20160001) approved the study.
Adipose tissue biopsy collection and analysis
At baseline, an adipose tissue biopsy was obtained from the buttocks according to the method
described by Beynen and Katan [19]. As described previously [10], a luer lock system (Terumo,
Terumo Corp, Tokyo, Japan) with a needle, a venoject multisample luer adaptor and an evacu-
ated blood tube was used. The samples were flushed with nitrogen and stored at -150˚C until
analysis. When analysed, the biopsies were thawed and a small amount of adipose tissue was
removed and heated at 50˚C for 10 min. Subsequently, at 50˚C, heptane dissolved the fat and
the fatty acids were transesterified for 2 min with 2 mol/L KOH, according to the International
Union of Pure and Applied Chemistry Standard Methods for the Analysis of Oils, Fats, and
Derivatives. The fatty acid composition was determined by gas chromatography using a Varian
3900 GC with a CP-8400 autosampler (Varian, Middleburg, The Netherlands) equipped with a
flame ionization detector. Constant flow, split injection mode and a CP-sil 88 60 m x 0.25-mm
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internal diameter capillary column and temperature programming from 90˚C to 210˚C were
used. Helium was used as the carrier gas, and commercially available standards (Nu-Chek-
Prep, Inc, Elysian, MN, US) were used to identify individual fatty acids [20]. Results for fatty
acids were given as percentages of total fatty acids.
Follow-up and outcome
Hospital discharge diagnoses have been registered in the Danish National Patient Register
since 1977. By linking the personal identification number for all study participants with this
register, information on AF/AFL development was obtained.
The 8th International Classification of Diseases (ICD-8, code 427.4 in the international ver-
sion, code 427.93/427.94 in the Danish version) was used until the end of 1993 and ICD-10
(code I.48.9x) subsequently. Follow-up was from baseline until first diagnosis of AF/AFL, emi-
gration, death or until July 31st 2013, whichever came first. The AF and AFL diagnoses have
previously been validated in this cohort with a positive predictive value above 92% [21].
Statistical analyses
In this case-cohort study, we used the treelet transform (TT) to derive sparse patterns of adi-
pose tissue fatty acids [16]. TT is a data-driven dimension-reducing method that produce a
Fig 1. Flowchart of the participants in the Diet, Cancer and Health cohort study.
https://doi.org/10.1371/journal.pone.0208833.g001
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number of factors/patterns, which account for much of the variation in the dataset. By creating
factors across variables based on the correlation of fatty acids, fatty acid compositions can be
expressed as patterns [16]. Not all fatty acids contribute to every pattern which eases the inter-
pretation and separates TT from the more widely used method principal component analysis
[17]. If an individual has a high score of a pattern this corresponds to that individual having an
adipose tissue fatty acid profile that matches the factor loadings well.
The output of TT is a dendrogram/cluster tree where the branches contains related groups
of variables. Patterns can be extracted by cutting the tree. Where to cut can be determined by
cross-validation with a range of different factors.
TT was applied to the correlation matrix of 32 adipose tissue fatty acids in the subcohort.
The optimal cut-off level was found according to a previously described method where a graph
of cross-validation scores is generated, and a point at which increasing the cut-level does not
substantially increase the cross-validation score, can be identified. Thus, the cut-level chosen is
the level where we can explain as much variation as possible, while maintaining as low a cut-
level as possible to simplify the interpretation of the patterns [22]. The factors were used to
generate scores (magnitude of each pattern) for participants in the subcohort, as well as cases
outside the subcohort according to each individual’s fatty acid profile.
Quintiles of the factor scores were used as exposure variables in weighted Cox proportional
hazards regression analyses with age as the time axis and the possibility of delayed entry. Par-
ticipants were treated as at risk from baseline until diagnosed with AF/AFL in the Danish
National Patient Register, death, emigration or end of follow-up, whichever came first. Partici-
pants with missing adipose tissue biopsies or missing data in one or more covariates were
excluded (Fig 1). In weighted Cox proportional hazards regression, used to account for the
case-cohort design, weights were assigned to each participant [23]. Adipose tissue was analysed
for all cases and thus, their assigned weight was one. For non-cases, adipose tissue for the ran-
domly drawn subcohort was weighed as (non-cases in the cohort)/(non-cases in the subco-
hort). All models were weighted and analysed for men and women separately and adjusted for
age at baseline in quintiles to ensure that the age of exposure data was comparable. We strati-
fied by sex as sex-specific differences in pathophysiology and epidemiology for AF have been
recognized [24]. Adjustments in the multivariate analyses were made for a list of predefined
potential confounders registered at baseline including lifestyle factors such as smoking (never,
former, <15, 15–25 or >25 g/day) and years in school (�7 years, 8–10,�10 years) as categori-
cal variables. Alcohol intake (g/day), body mass index (kg/m2) and waist circumference (cm)
were adjusted for as continuous variables using restricted cubic splines with five knots (Model
1A). Model 2 was adjusted for the confounders in Model 1A and for comorbidities at baseline
including history of hypercholesterolemia and/or cholesterol lowering treatment (yes/no), his-
tory of hypertension and/or treatment for hypertension (yes/no), angina pectoris (yes/no),
heart failure (yes/no), previous myocardial infarction (yes/no), diabetes mellitus (yes/no) and
renal disease (yes/no) as categorical variables. Data on diseases were retrieved from national
registries.
The reported hazard ratio (HR) corresponds to a comparison between 2 subjects of the
same sex with the same values of covariates.
Data were analysed using Stata statistical software (version 15, StataCorp LP, College Sta-
tion, US) and the associated TT package [22].
Results
A total of 4,710 participants developed documented AF during a median follow-up of 14.6
years. Baseline characteristics of the randomly drawn subcohort and all cases (including cases
Adipose tissue fatty acid patterns and AF
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in the subcohort) are shown in Table 1. A greater number of men (n = 2,907) than women
(n = 1,803) were cases. In the subcohort 271 participants developed AF (183 men and 88
women).
TT analyses were performed and resulted in the treelet dendrogram/cluster tree shown in
Fig 2. The optimal cut-level for the cluster tree was found to be 23 and the optimal number of
factors to retain was seven. The 7 patterns cumulatively explained 66% of the fatty acid vari-
ance in the subcohort and contained 8 fatty acids at most. Of the 32 fatty acids in the analysis
all, except C18:1 n-9 and C18:3 n-6, were contained in one pattern (Table 2). TT1 contained
saturated fatty acids (SFA), TT2 consisted of trans fatty acids, TT3 consisted of marine n-3
PUFA, TT4 contained n-6 PUFA (except linoleic acid), TT5 contained n-9 fatty acids, TT6
consisted of minor products of stearoyl-CoA desaturase and TT7 consisted of the plant-based
n-3 PUFA α-linolenic acid and the n-6 PUFA linoleic acid. TT factor scores were divided into
quintiles for men and women and hazard ratios (HR) were calculated for each factor with the
first quintile as the reference (Table 3 (men) and Table 4 (women)).
We consider Model 1A the primary model as this was adjusted for lifestyle factors. For men
(Table 3) there were a neutral association between SFA (TT1) and development of AF. The
trans fatty acids pattern (TT2) did not reach a statistically significant association in any of the
quintiles and the p-value for trend was also non-significant (0.08). The marine n-3 PUFA
Table 1. Baseline characteristics of participants and cases.
Men Women
Subcohort (n = 1,693) Cases (n = 2,907) Subcohort (n = 1,437) Cases
(n = 1,803)
Age at entry (years) 56.3
(50.8;64.3)
58.1 (51.0;64.6) 56.3
(50.7;63.8)
59.3 (51.2;64.7)
Hypertension (self-reported) 15.3 (259) 22.6 (656) 16.8 (241) 26.6 (480)
Systolic blood pressure (mmHg) 140
(114;178)
144 (116;184) 136
(108;173)
142 (110:182)
Diastolic blood pressure (mmHg) 84 (69;103) 86 (70;105) 81 (66;98) 83 (67;100)
Body-mass index (kg/m2) 26.4
(22.2;33.0)
27.0 (22.2;35.2) 24.7 (19.8;34.2) 25.8 (20.2;36.8)
Waist circumference (cm) 96 (83;114) 98 (84;119) 80 (67;105) 83 (69;108)
Alcohol (g/day) 19.7
(1.4;79.5)
21.2 (1.8;84.7) 9.6
(0.5;41.4)
7.8 (0.2;44.2)
Hypercholesterolemia (self-reported) 9.5 (161) 9.6 (279) 5.9 (85) 8.9 (160)
Serum total cholesterol (mmol/L) 5.9 (4.4;7.8) 5.9 (4.3;7.9) 6.2 (4.5;8.4) 6.2 (4.5;8.5)
Smoking
Never 26.8 (453) 25.8 (749) 44.8 (644) 41.0 (740)
Former 35.2 (595) 35.4 (1,030) 22.4 (322) 24.3 (438)
Current <15 g/day 11.2 (189) 10.2 (296) 15.9 (229) 15.5 (279)
Current 15–25 g/day 16.5 (279) 19.0 (552) 14.5 (209) 16.0 (289)
Current >25 g/day 10.5 (177) 9.6 (280) 2.3 (33) 3.2 (57)
Years in school >10 years 25.0 (423) 22.0 (638) 19.4 (279) 14.4 (259)
Angina pectoris (self-reported) 3.9 (66) 6.3 (182) 2.1 (30) 3.7 (67)
Diabetes mellitus 2.6 (44) 3.3 (97) 1.3 (19) 2.7 (48)
Renal disease 1.6 (27) 3.8 (110) 1.9 (27) 2.6 (47)
Previous myocardial infarction 3.0 (51) 4.2 (123) 0.3 (4) 1.2 (22)
Heart failure 0.2 (4) 0.6 (18) 0.1 (2) 0.5 (9)
% (number) or median (5th; 95th percentile).
https://doi.org/10.1371/journal.pone.0208833.t001
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pattern (TT3) was not associated with the hazard of AF. The n-6 PUFA pattern (TT4) was
associated with a statistically significant lower hazard of AF in quintiles 2–5 compared to the
first quintile, which was supported by a p-value of 0.0000 for trend. For the n-9 fatty acid pat-
tern (TT5) and stearoyl-CoA desaturase products (TT6) we found no consistent associations.
For the α-linolenic acid and linoleic acid (TT7) pattern there may be an association between
α-linolenic acid and linoleic acid and a higher hazard of AF with a p-value for trend of 0.03,
while none of the quintiles reached statistical significance.
Among women (Table 4), no clear association for saturated fatty acids was found. There
were no statistically significant association for trans fatty acids and AF when considering the
individual hazard ratios but the p-value for trend was 0.06. For the marine n-3 PUFA pattern a
negative association was observed. However, when exploring the quintiles, only the HR in
quintile 5 was statistically significant associated with development of AF. For the n-6 PUFA
pattern, the p-value for trend was 0.0001 and the HR for quintile 5 compared to the first quin-
tile was 0.55 (95% CI 0.45 to 0.75) suggesting a lower hazard of AF, while none of the other
quintiles reached statistical significance. In the n-9 fatty acids pattern the HR for quintile 5
compared to the first quintile was 0.70 (95% CI 0.52 to 0.93), also quintile 2 and 4 was associ-
ated with a lower risk of AF compared to quintile 1, and the p-value for trend was 0.01 suggest-
ing a lower hazard of AF. For TT6 and TT7 neutral associations with AF was observed.
Fig 2. Treelet transform dendrogram of the 32 fatty acids in adipose tissue determined in the subcohort (n = 3,130). The horizontal line indicates
the optimal cut at level 23.
https://doi.org/10.1371/journal.pone.0208833.g002
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Discussion
This large study of 4,710 cases of AF investigated patterns of fatty acids in adipose tissue and
the future risk of developing AF.
Our study had several strengths: We studied the naturally occurring adipose tissue fatty
acid patterns and the risk of incident AF in a large cohort with long and almost complete fol-
low-up for vital status. Also, the follow-up used national registries and the diagnoses of AF in
the cohort were validated with a positive predictive value >92% [21]. Instances of
Table 2. Fatty acid loadings on treelet transform factors.
Fatty acid Common name Mean SD Factor loading
TT1 TT2 TT3 TT4 TT5 TT6 TT7
12:0 Lauric acid 0.4 0.1 0.3
14:0 Myristic acid 2.7 0.5 0.4
14:1n-5 Nonadecanoic acid 0.4 0.1 0.6
15:0 Pentadecanoic acid 0.3 0.1 0.4
16:0 Palmitic acid 20.2 2.0 0.2
16:1n-7 Palmitoleic acid 6.6 1.6 0.5
17:0 Heptadecanoic acid 0.2 <0.1 0.4
18:0 Stearic acid 3.5 1.0 0.4
18:1n-6+8 (Δ12t+Δ10t)� 0.3 0.1 0.5
18:1n-9 (Δ9t) Elaidic acid 0.6 0.2 0.5
18:1n-8 (Δ10t) 0.3 0.1 0.5
18:1n-7 (Δ11t) Vaccenic acid 0.3 0.1 0.4
18:1n-10+12 (Δ8t+Δ6t)� 1.5 0.4 0.5
18:1n-9 Oleic acid 44.0 2.0
18:1n-7 Asclepic acid 2.0 0.4 0.4
18:2n-7 (Δ9c11t) Rumenic acid 0.4 0.1 0.6
18:2n-6 Linoleic acid 10.7 1.9 0.7
18:3n-3 α-linolenic acid 0.8 0.2 0.7
18:3n-6 γ-linolenic acid 0.1 <0.1
19:0 Nonadecanoic acid 0.1 <0.1 0.4
20:0 Arachidic acid 0.2 0.1 0.5
20:1n-9 n-9 eicosenoic acid 0.8 0.2 0.5
20:1n-11 n-11 eicosenoic acid 0.2 0.1 0.5
20:2n-6 Eicosadienoic acid 0.2 <0.1 0.3
20:3n-6 Dihomo-γ-linolenic acid 0.2 0.1 0.5
20:4n-3 Eicosatetraenoic acid 0.1 <0.1 0.5
20:4n-6 Arachidonic acid 0.4 0.1 0.5
20:5n-3 Eicosapentaenoic acid 0.1 <0.1 0.5
22:1n-9 Eurcic acid 0.1 <0.1 0.5
22:4n-6 Docosatetraenoic acid 0.1 <0.1 0.5
22:5n-3 Docosapentaenoic acid 0.3 0.1 0.5
22:6n-3 Docosahexaenoic acid 0.3 0.1 0.5
Explained variance (%) 14.2 11.7 10.0 9.2 8.7 7.4 4.6
Standard deviation, SD
Mean percentage of fatty acids in adipose tissue (% of total fatty acids) and standard deviation, their loadings on treelet transform factors and the explained variance of
extracted factors for participants in the subcohort (n = 3,130).
�The peaks for 18:1n-6 (Δ12t) and 18:1n-8 (Δ10t) and 18:1n-10 (Δ8t) and 18:1n-12 (Δ6t) could not be separated in the analysis
https://doi.org/10.1371/journal.pone.0208833.t002
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Table 3. Results for men.
Fatty acid pattern Factor score quintile HR (95% CI)
Model 1� Model 1A† Model 2‡
TT1 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Saturated fatty acids 2. 0.80 (0.65–0.97) 0.92 (0.75–1.12) 0.99 (0.81–1.22)
3. 0.88 (0.73–1.07) 1.06 (0.87–1.30) 1.14 (0.93–1.40)
4. 0.67 (0.56–0.82) 0.89 (0.72–1.09) 0.97 (0.78–1.19)
5. 0.57 (0.47–0.70) 0.82 (0.65–1.02) 0.89 (0.71–1.11)
P(trend) 0.0000 0.11 0.41
TT2 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Trans fatty acids 2. 0.91 (0.75–1.11) 1.00 (0.82–1.24) 1.02 (0.83–1.25)
3. 0.88 (0.72–1.07) 1.04 (0.84–1.29) 1.07 (0.86–1.33)
4. 0.95 (0.78–1.16) 1.10 (0.89–1.36) 1.14 (0.91–1.40)
5. 0.94 (0.77–1.14) 1.20 (0.96–1.52) 1.25 (0.99–1.58)
P(trend) 0.71 0.08 0.03
TT3 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Marine n-3 PUFA 2. 1.40 (1.15–1.71) 1.25 (1.01–1.53) 1.29 (1.05–1.60)
3. 1.18 (0.97–1.44) 1.02 (0.83–1.26) 1.05 (0.85–1.30)
4. 1.35 (1.11–1.65) 1.22 (0.99–1.50) 1.23 (0.99–1.53)
5. 1.07 (0.87–1.31) 0.93 (0.75–1.16) 0.95 (0.76–1.19)
P(trend) 0.83 0.37 0.40
TT4 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
n-6 PUFA 2. 0.72 (0.60–0.87) 0.66 (0.54–0.81) 0.65 (0.53–0.80)
3. 0.72 (0.60–0.88) 0.60 (0.49–0.73) 0.60 (0.49–0.74)
4. 0.85 (0.71–1.03) 0.62 (0.50–0.77) 0.58 (0.46–0.72)
5. 0.98 (0.81–1.18) 0.54 (0.43–0.68) 0.48 (0.38–0.61)
P(trend) 0.85 0.0000 0.0000
TT5 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
n-9 fatty acids 2. 0.95 (0.78–1.16) 1.05 (0.86–1.30) 1.12 (0.90–1.39)
3. 0.91 (0.75–1.11) 1.09 (0.88–1.35) 1.15 (0.92–1.43)
4. 0.93 (0.76–1.12) 1.16 (0.94–1.44) 1.24 (0.99–1.55)
5. 0.71 (0.58–0.87) 0.92 (0.72–1.17) 0.99 (0.77–1.25)
P(trend) 0.0027 0.92 0.67
TT6 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Stearoyl-CoA desaturase 2. 0.98 (0.80–1.19) 0.96 (0.78–1.18) 0.95 (0.77–1.18)
3. 1.12 (0.92–1.37) 1.12 (0.92–1.38) 1.16 (0.95–1.43)
4. 1.12 (0.92–1.36) 1.06 (0.86–1.30) 1.04 (0.85–1.29)
5. 1.24 (1.02–1.52) 1.12 (0.91–1.38) 1.17 (0.95–1.44)
P(trend) 0.01 0.16 0.09
TT7 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
α-linolenic acid 2. 0.76 (0.63–0.93) 0.84 (0.68–1.04) 0.81 (0.66–1.00)
Linoleic acid 3. 0.74 (0.61–0.90) 0.85 (0.68–1.05) 0.84 (0.68–1.04)
4. 0.82 (0.67–1.00) 0.99 (0.80–1.22) 0.97 (0.78–1.20)
5. 0.95 (0.78–1.15) 1.19 (0.96–1.47) 1.18 (0.96–1.47)
P(trend) 0.91 0.03 0.03
Confidence interval, CI
Polyunsaturated fatty acids, PUFA
Hazard ratio (HR) with 95% confidence interval for developing atrial fibrillation in quintiles with the first quintile as the reference. P-value for trend.
�Adjusted for age at baseline in quintiles
†Adjusted for model 1 and body mass index (kg/m2), waist circumference (cm), smoking (never, former, <15, 15–25, >25 g/day), alcohol (g/day), years in school (�7
years, 8–10 years,�10 years)
‡Adjusted for model 1A and for hypertension (yes or medication, no, not known), hypercholesterolemia (yes or medication, no, not known), diabetes mellitus (yes, no),
angina pectoris, previous myocardial infarction (yes, no), heart failure (yes, no), renal disease (yes, no)
https://doi.org/10.1371/journal.pone.0208833.t003
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Table 4. Results for women.
Fatty acid pattern Factor score quintile HR (95% CI)
Model 1� Model 1A† Model 2‡
TT1 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Saturated fatty acids 2. 0.72 (0.57–0.90) 0.78 (0.61–1.00) 0.80 (0.63–1.03)
3. 0.84 (0.67–1.06) 0.99 (0.77–1.26) 1.03 (0.80–1.32)
4. 0.73 (0.58–0.93) 0.92 (0.71–1.18) 0.92 (0.71–1.19)
5. 0.57 (0.45–0.73) 0.76 (0.58–0.99) 0.80 (0.61–1.05)
P(trend) 0.0001 0.22 0.34
TT2 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Trans fatty acids 2. 1.07 (0.84–1.36) 1.13 (0.88–1.46) 1.15 (0.88–1.50)
3. 1.31 (1.03–1.66) 1.47 (1.14–1.91) 1.59 (1.21–2.07)
4. 1.08 (0.85–1.37) 1.27 (0.98–1.66) 1.39 (1.06–1.82)
5. 1.07 (0.84–1.36) 1.30 (0.99–1.72) 1.44 (1.08–1.91)
P(trend) 0.65 0.06 0.01
TT3 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Marine n-3 PUFA 2. 0.86 (0.67–1.10) 0.82 (0.64–1.06) 0.82 (0.64–1.06)
3. 1.07 (0.85–1.36) 0.94 (0.74–1.21) 0.96 (0.75–1.23)
4. 0.98 (0.77–1.24) 0.83 (0.64–1.07) 0.82 (0.63–1.07)
5. 0.71 (0.56–0.91) 0.63 (0.48–0.82) 0.60 (0.45–0.78)
P(trend) 0.04 0.002 0.0007
TT4 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
n-6 PUFA 2. 1.05 (0.83–1.34) 0.93 (0.72–1.19) 0.91 (0.70–1.17)
3. 1.08 (0.85–1.38) 0.86 (0.66–1.11) 0.82 (0.63–1.06)
4. 1.07 (0.85–1.36) 0.77 (0.59–1.00) 0.73 (0.56–0.96)
5. 0.98 (0.77–1.25) 0.55 (0.41–0.75) 0.47 (0.35–0.64)
P(trend) 0.92 0.0001 0.0000
TT5 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
n-9 fatty acids 2. 0.68 (0.54–0.86) 0.76 (0.59–0.98) 0.77 (0.60–1.00)
3. 0.66 (0.53–0.84) 0.77 (0.60–1.00) 0.80 (0.61–1.04)
4. 0.58 (0.46–0.74) 0.68 (0.51–0.89) 0.73 (0.55–0.96)
5. 0.55 (0.44–0.70) 0.70 (0.52–0.93) 0.72 (0.54–0.97)
P(trend) 0.0027 0.01 0.03
TT6 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Stearoyl-CoA desaturase 2. 1.00 (0.78–1.27) 1.05 (0.82–1.35) 1.07 (0.83–1.39)
3. 1.00 (0.79–1.27) 1.05 (0.82–1.35) 1.10 (0.85–1.42)
4. 1.09 (0.86–1.38) 1.19 (0.92–1.52) 1.22 (0.95–1.57)
5. 1.07 (0.84–1.35) 1.16 (0.91–1.50) 1.23 (0.95–1.59)
P(trend) 0.41 0.13 0.07
TT7 1. 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
α-linolenic acid 2. 0.87 (0.68–1.10) 0.87 (0.68–1.12) 0.88 0.68–1.12)
Linoleic acid 3. 0.90 (0.71–1.14) 0.91 (0.71–1.16) 0.90 (0.70–1.15)
4. 0.85 (0.67–1.08) 0.84 (0.65–1.09) 0.84 (0.65–1.09)
5. 0.99 (0.78–1.25) 1.00 (0.78–1.29) 1.00 (0.78–1.29)
P(trend) 0.91 0.95 0.94
Confidence interval, CI
Polyunsaturated fatty acids, PUFA
Hazard ratio (HR) with 95% confidence interval for developing atrial fibrillation in quintiles with the first quintile as the reference. P-value for trend.
�Adjusted for age at baseline in quintiles
†Adjusted for model 1 and body mass index (kg/m2), waist circumference (cm), smoking (never, former, <15, 15–25, >25 g/day), alcohol (g/day), years in school (�7
years, 8–10 years,�10 years)
‡Adjusted for model 1A and for hypertension (yes or medication, no, not known), hypercholesterolemia (yes or medication, no, not known), diabetes mellitus (yes, no),
angina pectoris, previous myocardial infarction (yes, no), heart failure (yes, no), renal disease (yes, no)
https://doi.org/10.1371/journal.pone.0208833.t004
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misclassification of AF cases were unlikely to be associated with the exposure and would there-
fore lead to an underestimation of associations between fatty acid patterns and the risk of AF.
Due to the large number of cases in both men and women, we were able to study the associa-
tion with incident AF in both sexes separately.
The study also had some limitations: The study participants were 50–64 years old at enrol-
ment and therefore the results may not be valid in other age groups. Also, participants were all
Caucasians so the results may not be valid for other ethnicities.
As in other cohort studies the highest degree of participation was among participants with
higher education. Also, married people were more likely to participate than single or cohabit-
ing persons. However, due to the present study being a case-cohort design non-participants
would only cause bias if the non-response was related to both the exposure, here adipose tissue
content of fatty acids, and also to the risk of the outcome of the study, which seems highly
unlikely [18].
We did not have information regarding the use of specific medications such as statins or
fibrates among participants in the cohort during follow-up. However, to our knowledge there
is no indication that these drugs affect the fatty acid composition in adipose tissue.
Adipose tissue samples were only obtained once. Thus, a change in the participants’ dietary
habits and metabolism could potentially change the composition of fatty acids in adipose tis-
sue, which this study was unable to capture. However, it is plausible that these middle-aged
participants had a fairly stable diet. Also, we used subcutaneous adipose tissue from the but-
tocks. Previous studies have suggested that the content of fatty acids may vary according to the
location of the subcutaneous adipose tissue. E.g. adipose tissue from the buttock may contain
more MUFA and less SFA than subcutaneous abdominal adipose tissue [13,14,25]. Further-
more, for example epicardial adipose tissue might have different metabolic properties than
subcutaneous adipose tissue concerning development of AF [26].
A recently published study [27] found higher levels of n-3 PUFA in the myocardium of dia-
betic patients compared to age-matched controls free from diabetes mellitus. In our study, we
adjusted the results for diabetes mellitus but did not have sufficient statistical power to analyse
data based on diabetes mellitus status at baseline.
We considered including physical activity but data on physical activity in this cohort were
sparse and previous studies on the cohort have shown that adjustment for physical activity
does not affect the results substantially. Finally, there is always a possibility of residual
confounding.
We used TT to derive patterns of fatty acids in adipose tissue as TT has previously been
used in the medical literature to create patterns of dietary data [17,28] and patterns of adipose
tissue content of fatty acids [29–31].
Several other methods have been suggested and applied for pattern analysis: principal com-
ponent analysis, factor analysis [32] and, more recently, structural equation modelling [33].
Each method has distinct strengths, limitations and assumptions. All these methods are
unsupervised, meaning the constructed patterns solely reflect the distribution in the popula-
tion in question without taking into account the potential association with study endpoint.
Thus, there is no guarantee of an associations between factors and the endpoint, although
some of the single variables contributing to a factor may be strong risk factors.
When constructing the cluster tree (dendrogram) the main assumption is the distinct corre-
lation structure with high correlation within factors and low correlations between factors.
TT identifies factors based on the sample correlation. These correlations may be attenuated
by the presence of analytical noise. This can be managed in methods with latent variables such
as factor analysis and structural equation modelling. However, the TT cluster tree is produced
based on the order of correlations and not their actual magnitude. If the analytical noise is
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reasonably independent and homogeneous, the order of correlations would be similar to
absence of analytical noise.
The sparsity of TT factors is simple to interpret, hence we have chosen this method as the
explorative technique used in this study. In the future, further confirmatory analyses could be
of interest.
The grouping of fatty acids in patterns may reflect shared dietary sources and metabolism
within the body, where the fatty acids compete for enzymes responsible for desaturation and
elongation of fatty acids [34]. In this study TT7 reflects shared dietary sources. A previous
study using principal component analysis on seven fatty acids in adipose tissue found that the
factors were based on the chemical structure of the fatty acids [35], which was also the case in
the present study. To our knowledge, no previous studies have evaluated the association
between adipose tissue patterns of fatty acids and the risk of AF. By using 32 adipose tissue
fatty acids and deriving patterns using TT, our study was able to condense information on
these adipose tissue fatty acids and determine the most correlated patterns prevalent in this
cohort study, while retaining a simple, sparse, structure to the extracted factors. Many of the
fatty acids in the extracted factors have not been described in relation to AF previously, and
our study contributes to expanding the literature for trans fatty acids, n-6 PUFA and n-9 fatty
acids, in particular. Clinicians and basic researchers can use this study, when considering
whether these fatty acids are related to the risk of AF. Furthermore, as fatty acids occur in pat-
terns, it is not possible to investigate the association between individual fatty acids and the risk
of diseases independent of the pattern the fatty acid occur in.
The existing literature regarding fatty acid patterns and the risk of developing AF, will be
discussed below in relation with the results of the present study.
Regarding SFA (TT1), previous studies have suggested that SFA replacing carbohydrates in
the diet and higher circulating plasma levels of C16:0 were associated with a higher risk of AF
[36,37]. In this study, we could not confirm an association between an adipose tissue pattern
high in SFA and a higher hazard of AF. Also, we have previously found in this cohort that
replacing dietary SFA with n-3 PUFA was associated with a moderately higher risk of AF in
men, while replacement with MUFA or other PUFA did not affect the risk [38]. Recently, we
also explored the association between adipose tissue content of the major individual SFA
(myristic (C14:0), palmitic (16:0) and stearic (C18:0) acid) and the risk of AF and did not find
an association [10]. In contrast, other investigators have reported that higher circulating
plasma levels of C16:0 were associated with a higher risk of AF in the highest compared to the
lowest quartile, while circulating levels of the longer chained SFA C18:0-C24:0 were associated
with a lower risk of AF [36]. However, as the present study explored patterns based on statisti-
cal correlations and the other studies explored individual SFA or hypothesis-driven SFA
groups (based on common dietary sources and length of the carbon chain) the results cannot
be directly compared.
Regarding an adipose tissue pattern with marine n-3 PUFA (TT3) a previous study on the
subcohort (179 cases of AF) used in our study showed that marine n-3 fatty acids in adipose
tissue were monotonic, negatively associated with development of AF, but the association was
not statistically significant [11]. Why an association was only found in women in this study is
unknown, but it might be explained by differences in metabolic processes caused by the differ-
ent sex hormones, albeit most women in the cohort were postmenopausal at enrolment [24].
As previously mentioned, we found no previous studies on trans fatty acids (TT2), n-6
PUFA (TT4) or n-9 fatty acids (TT5), and the risk of developing AF. The minor products of
stearoyl-CoA desaturase (TT6) were not significantly associated with the hazard of AF. The
major product of stearoyl-CoA desaturase is oleic acid (C18:1 n-9) which is the most abundant
fatty acid in adipose tissue and not included in any factors [13,34]. TT derives factors
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balancing interpersonal variation and variable correlation. Thus, abundant fatty acids such as
oleic acid may not vary greatly between individuals and therefore will not be retained in a fac-
tor. However, the minor products in TT6 may show greater variation between individuals and
will therefore be retained. The dietary intake of palmitoleic acid (C16:1 n-7) is low but is rela-
tively abundant in adipose tissue due to endogenous synthesis [39] and our neutral findings
suggest that palmitoleic acid is not important for the development of AF. A pattern with α-lin-
olenic and linoleic acid (TT7) showed a trend towards a higher hazard of AF in men after
adjustment for lifestyle, but not in women. Previous studies have not found an association
with either dietary intake, or plasma or serum concentrations of α-linolenic acid and the risk
of AF [40,41]. Furthermore, in the Framingham Heart Study, a combined dietary intake of ara-
chidonic and linoleic acid was not associated with AF [42].
Conclusions
We here report associations between patterns of fatty acids in adipose tissue identified by TT
and the risk of developing AF. In both men and women, patterns with n-6 PUFA (TT4) may
be associated with a lower hazard of AF. Patterns with marine n-3 PUFA (TT3) and n-9 fatty
acids (TT5) were associated with a lower hazard of AF in women, while in men, patterns with
α-linolenic acid and linoleic acid (TT7) may be associated with a higher hazard of AF.
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